Complementing mutations in core binding factor leukemias : from mouse models to clinical applicationsMULLER, A. M. S; DUQUE, J; SHIZURU, J. A et al.Oncogene (Basingstoke). 2008, Vol 27, Num 44, pp 5759-5773, issn 0950-9232, 15 p.Article

CD34⁺ or CD34^-: which is the more primitive?ENGELHARDT, M; LÜBBERT, M; GUO, Y et al.Leukemia. 2002, Vol 16, Num 9, pp 1603-1608, issn 0887-6924Article

Acute myelomonocytic leukemia secondary to synchronous carcinomas of the breast and lung, and to metachronous renal cell carcinomaPÖTZSCH, C; FETSCHER, S; MERTELSMANN, R et al.Journal of cancer research and clinical oncology. 1997, Vol 123, Num 11-12, pp 678-680, issn 0171-5216Article

Stable methylation patterns of MYC and other genes regulated during terminal myeloid differentiationLÜBBERT, M; SALSER, W; PROKOCIMER, M et al.Leukemia. 1991, Vol 5, Num 7, pp 533-539, issn 0887-6924Article

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): A multicenter studyGERMING, U; LAUSEKER, M; MACIEJEWSKI, J et al.Leukemia. 2012, Vol 26, Num 6, pp 1286-1292, issn 0887-6924, 7 p.Article

Leukemia targeting ligands isolated from phage display peptide librariesJÄGER, S; JAHNKE, A; WILMES, T et al.Leukemia. 2007, Vol 21, Num 3, pp 411-420, issn 0887-6924, 10 p.Article

ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETOLAUSEN, J; LIU, S; FLIEGAUF, M et al.Oncogene (Basingstoke). 2006, Vol 25, Num 9, pp 1349-1357, issn 0950-9232, 9 p.Article

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome : A multicenter phase II study in elderly patientsWIJERMANS, P; LÜBBERT, M; VERHOEF, G et al.Journal of clinical oncology. 2000, Vol 18, Num 5, pp 956-962, issn 0732-183XArticle

HTLV-I-associated adult T cell leukemia/lymphoma in two patients from Bucharest, RomaniaVEELKEN, H; KÖHLER, G; SCHNEIDER, J et al.Leukemia. 1996, Vol 10, Num 8, pp 1366-1369, issn 0887-6924Article

Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cellsLÜBBERT, M; HERRMANN, F; KOEFFLER, H. P et al.Blood. 1991, Vol 77, Num 5, pp 909-924, issn 0006-4971Article

Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blastsHERRMANN, F; LINDEMANN, A; KLEIN, H et al.Leukemia. 1989, Vol 3, Num 5, pp 335-338, issn 0887-6924Article

Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancer-binding protein-αJIANG, Y; XUE, Z.-H; HUANG, Y et al.Leukemia. 2005, Vol 19, Num 7, pp 1239-1247, issn 0887-6924, 9 p.Article

Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanismsSCHMELZ, K; SATTLER, N; WAGNER, M et al.Leukemia. 2005, Vol 19, Num 1, pp 103-111, issn 0887-6924, 9 p.Article

Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective studyBEHRINGER, B; PITAKO, J. A; KUNZMANN, R et al.Annals of hematology (Print). 2003, Vol 82, Num 7, pp 381-389, issn 0939-5555, 9 p.Article

Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia : biological implicationsNGUYEN, T. T; MOHRBACHER, A. F; TSAI, Y. C et al.Blood. 2000, Vol 95, Num 9, pp 2990-2992, issn 0006-4971Article

DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies : Clinical results and possible mechanisms of actionLÜBBERT, M.Current Topics in Microbiology and Immunology. 2000, Vol 249, pp 135-164, issn 0070-217XArticle

Familial and metachronous malignant lymphoma : Absence of constitutional p53 mutationsPÖTZSCH, C; SCHAEFER, H.-E; LÜBBERT, M et al.American journal of hematology. 1999, Vol 62, Num 3, pp 144-149, issn 0361-8609Article

Drug resistance of secondary acute myeloid leukemia with megakaryoblastic features and p190 BCR-ABL rearrangementVEELKEN, H; LICHT, T; LAIS, A et al.Leukemia research. 1998, Vol 22, Num 11, pp 1021-1027, issn 0145-2126Article

Clonal analysis of bcr-abl rearrangement in T lymphocytes from patients with chronic myelogenous leukemiaJONAS, D; LÜBBERT, M; KAWASAKI, E. S et al.Blood. 1992, Vol 79, Num 4, pp 1017-1023, issn 0006-4971Article

A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemiasLÜBBERT, M; OSTER, W; LUDWIG, W.-D et al.Blood. 1992, Vol 80, Num 8, pp 2066-2073, issn 0006-4971Article

Cytosine demethylation of the proteinase-3/myeloblastin primary granule protease gene during phagocyte developmentLÜBBERT, M; TOBLER, A; DASKALAKIS, M et al.Leukemia. 1999, Vol 13, Num 9, pp 1420-1427, issn 0887-6924Article

Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiationLÜBBERT, M; MILLER, C. W; KOEFFLER, H. P et al.Blood. 1991, Vol 78, Num 2, pp 345-356, issn 0006-4971Article

Robust in vivo differentiation of t(8;21 )-positive acute myeloid leukemia blasts to neutrophilic granulocytes induced by treatment with dasatinibCHEVALIER, N; SOLARI, M. L; BECKER, H et al.Leukemia. 2010, Vol 24, Num 10, pp 1779-1781, issn 0887-6924, 3 p.Article

Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation : models for the 'second hit' hypothesisBECKER, H; PFEIFER, D; AFONSO, J. D et al.Leukemia. 2008, Vol 22, Num 9, pp 1792-1794, issn 0887-6924, 3 p.Article

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cellsBARBETTI, V; GOZZINI, A; ROVIDA, E et al.Oncogene (Basingstoke). 2008, Vol 27, Num 12, pp 1767-1778, issn 0950-9232, 12 p.Article